About Medgel Private Limited
Data last updated:
Medgel Private Limited is a private limited company based in Indore, Madhya Pradesh, India, a subsidiary of Medicaps Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2007PTC019204. Its GSTIN is 23AAECM9146J2Z9 (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.68 Cr. It was formerly known as Medgel Pharmaceuticals Private Limited. It is led by directors including Alok K Garg (Managing Director) and Manisha Garg (Whole-Time Director).
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 Pushpratna Paradise 9/5 New Palasiya Opposite Uco Bank, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.23 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹1.13 Cr (net margin -4.5%) and EBITDA of ₹45.68 Lakh (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 5% over five years.
The company has about 151 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.3 Cr and satisfied charges of ₹24.32 Cr on record. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹47.31 Cr; the latest was in February 2024. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Laxmi Supertech Private Limited with revenue of ₹25.53 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medgel.net.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address201 Pushpratna Paradise 9/5 New Palasiya Opposite Uco Bank, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medgel Private Limited
The main business activity of Medgel is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medgel Private Limited FY 2025 filings available
Medgel Private Limited reported revenue of ₹25.23 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medgel Private Limited
Revenue rose 23% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medgel Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹45.68 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.13 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medgel Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medgel are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medgel Private Limited
Medgel Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laxmi Supertech Private Limited | ₹25.53 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Agra, Uttar Pradesh, India |
| Deep Meditech Private Limited | ₹25.51 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Delhi, India |
| D R Johns Lab Private Limited | ₹25.41 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | New Delhi, Delhi, India |
| Keylink Global Exim Private Limited | ₹25.39 Cr (FY 2025) | •••• | •••• | 324.0% | •••• | Jaipur, Rajasthan, India |
| Synchem Laboratories Private Limited | ₹25.3 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Baroda, Gujarat, India |
| Medgel Private Limited this company | ₹25.23 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Indore, Madhya Pradesh, India |
| Tanmed Pharma India Private Limited | ₹25.2 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Chennai, Tamil Nadu, India |
| Ornate Labs Private Limited | ₹25.2 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Muzaffarpur, Bihar, India |
| JMB Pharmaceuticals Private Limited | ₹25.18 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| Piramal Phytocare Limited | ₹25.17 Cr (FY 2019) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Fitwel Pharmaceuticals Private Limited | ₹25.09 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Medgel by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medgel Private Limited
Medgel Private Limited is audited by RAWKA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAWKA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medgel Private Limited
Medgel has 6 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Agrawal Omprakash Also directs: Medicaps Limited | Director | 03 Feb 2020 | 6 Years 8 Months | Current |
| Akshit Garg | Director | 20 Nov 2019 | 6 Years 10 Months | Current |
| Manisha Garg | Whole-Time Director | 27 Aug 2016 | 10 Years 1 Months | Current |
| Praveen Nalwaya | Whole-Time Director | 01 Mar 2014 | 12 Years 7 Months | Current |
| Ramesh Chandra Mittal | Director | 01 Apr 2009 | 17 Years 6 Months | Current |
| Alok K Garg Also directs: Medicaps Limited | Managing Director | 10 Jan 2007 | 19 Years 8 Months | Current |
Ownership and Shareholding of Medgel Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medgel Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2024 | Others | ₹80 Lakh | Open |
| 09 Sep 2009 | Idbi Bank Limited | ₹7.5 Cr | Open |
| 20 Mar 2023 | Others | ₹20 Cr | Satisfied |
| 05 May 2022 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
| 09 Feb 2022 | Others | ₹31.5 Lakh | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Medgel Private Limited
Medgel Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹47.31 Cr; the latest was in February 2024.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Secondary share transfer | Undisclosed | Buyer: Medicaps Limited & Manisha Garg, Medicaps Limited & Saloni Garg, Medicaps Limited & Palash Garg Seller: Medicaps Limited |
| Mar 2017 | Funding round | ₹9.7 Cr | Investors: Medicaps Limited |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: Medicaps Limited Seller: Mission Vivacare Limited |
| Mar 2014 | Funding round | ₹9.4 Cr | Investors: Medicaps Limited |
| Oct 2011 | Funding round | ₹22.77 Cr | Investors: Medicaps Limited , Mission Vivacare Limited |
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Medgel Private Limited
Medgel Private Limited has a workforce of 151 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medgel Private Limited
Medgel Private Limited has 15 board changes on record since 2007: 6 appointments and 9 cessations. The latest: Ashok Agrawal Omprakash ceased to be Additional Director on 30 Dec 2020.
18 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medgel Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medgel Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medgel Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medgel Private Limited
Medgel has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECM9146J2Z9 | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medgel Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medgel Private Limited
Medgel is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2007 (19+ years old) and is registered under CIN U24239MP2007PTC019204.
Medgel reported revenue of ₹25.23 Cr for FY 2025 (up 23% YoY).
Medgel has 6 current directors:
- Alok K Garg - Managing Director
- Manisha Garg - Whole-Time Director
- Praveen Nalwaya - Whole-Time Director
- Ashok Agrawal Omprakash - Director
- Akshit Garg - Director
- Ramesh Chandra Mittal - Director
Medgel reported a net loss of ₹1.13 Cr (net margin -4.5%) and EBITDA of ₹45.68 Lakh (EBITDA margin 1.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medgel is -29% over three years and -5% over five years. In the latest year (FY 2025) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medgel is 23AAECM9146J2Z9, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medgel is U24239MP2007PTC019204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medgel was incorporated on 10 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Gwalior.
Medgel has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹47.31 Cr; the latest was in February 2024.
The peers of Medgel by revenue are Laxmi Supertech Private Limited, Deep Meditech Private Limited, D R Johns Lab Private Limited, Keylink Global Exim Private Limited, Synchem Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Ashok Agrawal Omprakash ceased to be Additional Director on 30 Dec 2020. Ashok Agrawal Omprakash was appointed as Director on 03 Feb 2020. Akshit Garg was appointed as Director on 20 Nov 2019. Medgel has 15 board changes on record in total.